Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07300020 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PK and Relative Bioavailability of Novel Liquid Metformin vs Tablets

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 23, 2025 (before its estimated June 15, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This is an open-label, randomized, three-period crossover study evaluating the single-dose pharmacokinetics and relative bioavailability of a novel liquid metformin formulation at concentrations of 100 mg/mL and 250 mg/mL compared with immediate-release metformin tablets in healthy adult subjects. All participants will receive each formulation in randomized sequence with washout periods between treatments. Serial blood samples will be collected to characterize metformin pharmacokinetic parameters, and safety and tolerability will be assessed throughout the study.
Trial Details
NCT Number NCT07300020
Lead Sponsor Aspargo Labs, Inc
Conditions
(from sponsor)		 Healthy Volunteer
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov